SCHEMBL4602279

SCHEMBL4602279

COCCOc1ccc(CCCN(C(=O)O)S(=O)(=O)N2CCC(C(N)=O)CC2)c(Oc2ncc(C(F)(F)F)cc2Cl)c1

nearest known ligand 0.56

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PPARG P37231 20/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3206800 0.93 PPARG (0.57) PPARG
SCHEMBL3204576 0.91 PPARG (0.58) PPARG
SCHEMBL4514106 0.88 PPARG (0.57) PPARG
SCHEMBL3210963 0.86 PPARG (0.56) PPARG
SCHEMBL3209499 0.83 PPARG (0.59) PPARG
SCHEMBL3213529 0.83 PPARG (0.63) PPARG
SCHEMBL3204633 0.83 PPARG (0.57) PPARG
SCHEMBL3204341 0.83 PPARG (0.59) PPARG
SCHEMBL3217488 0.83 PPARG (0.59) PPARG
SCHEMBL4515286 0.82 PPARG (0.68) PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1912645-A2 THERAPEUTIC AGENT FOR DIABETES Takeda Pharmaceutical Company Limited (JP) 2008-04-23 EP disclosed
WO-2007018314-A2 THERAPEUTIC AGENT FOR DIABETES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-02-15 WO disclosed